Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2004-05-13
2009-06-16
Mondesi, Robert B (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
07547762
ABSTRACT:
The present disclosure relates to T24 nucleic acid sequences, amino acid sequences, and antibodies. Methods for detecting and diagnosingTaenia soliuminfection in a subject using the T24 sequences and specific binding agents are also disclosed. The T24 sequences disclosed herein can be formulated into a pharmaceutical composition for administration to a subject. For example, the disclosed T24 polypeptides can also be administered to a subject to stimulate an immune response in the subject, thereby protecting the subject againstT. soliuminfection.
REFERENCES:
patent: 4740456 (1988-04-01), Kuhn et al.
patent: 4801532 (1989-01-01), Kuhn et al.
patent: 5354660 (1994-10-01), Tsang et al.
patent: 5874251 (1999-02-01), Zarlenga, Jr. et al.
patent: 6156505 (2000-12-01), Steinbruch et al.
patent: 6331388 (2001-12-01), Malkovsky et al.
patent: 6379906 (2002-04-01), Tsang et al.
patent: WO 01/10897 (2001-02-01), None
Maniatis et al 1989 Molecular Cloning; Laboratory Manual Champer 12).
Plancarte et al 1999 International Journal for Parasitology pp. 643-647.
Plancarte et al 1994 International Journal for Parasitology vol. 24 No. 5 pp. 733-738.
Greenspan et al. 1999 Nature Biotechnology 17: 936-937.
Gonzalez et al 2001 Am. J. Trop. Med. Hyg. vol. 65 No. 1 pp. 15-18.
Sotelo et al 2002 Neurosurg. Focus vol. 12 pp. 1-7.
Bowie et al Science, 1990, 247:1306-1310.
Gerhold et al [BioEssays, vol. 18, pp. 973-981 {1996}].
GenBank Accession No. BF643023 (Dec. 19, 2000).
Ito et al., “Recent Advances in Basic and Applied Science for the Control of Taeniasis/Cysticercosis in Asia,”Southeast Asian J. Trop. Med Public Health 33:79-82 (2002).
GenBank Accession No. BQ173191 (Sep. 18, 2002).
de Aluja et al., “ExperimentalTaenia soliumCysticercosis in Pigs: Characteristics of the Infection and Antibody Response,”Vet. Parasitol. 61:49-59 (1996).
Greene et al., “Taenia solium: Molecular Cloning and Serologic Evaluation of 14- and 18-KDA Related, Diagnostic Antigens,”J. Parasitol. 86:1001-1007 (2000).
Hancock et al., “Characteristics of Six Proteins, Diagnostic for Cysticercosis,”Abstracts of the General Meeting of the American Society for Microbiology and ASM 102ndGeneral Meeting 102:127 (2002).
Plancarte et al., “Characterization of GP39-42 and GP24 Antigens fromTaenia soliumCysticerci and their Antigenic GP10 Subunit,”Parasitol. Res. 85:680-684 (1999).
Plancarte et al., “Reactivity in ELISA and Dot Blot of Purified GP24, an Immunodominant Antigen ofTaenia solium, for the Diagnosis of Human Neurocysticercosis,”Int.. J. Parasitol. 24:733-738 (1994).
Hancock Kathy
Pattabhi Sowmya
Tsang Victor C. W.
Whitfield Fatima Williams
Yushak Melinda L.
Archie Nina A
Klarquist & Sparkman, LLP
Mondesi Robert B
The United States of America as represented by the Department of
LandOfFree
T24 antigen for immunodiagnosis of Taenia solium... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with T24 antigen for immunodiagnosis of Taenia solium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T24 antigen for immunodiagnosis of Taenia solium... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4081347